Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Fischer

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Digestive Diseases and Sciences|October 8, 2017
Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-UpMonika Fischer, Sarah C Campbell, Cynthia S J Calley, et al.
Journal of Gastroenterology and Hepatology|March 8, 2021
Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infectionSanchit Gupta, Jinyi Zhu, Thomas R McCarty, et al.
The American Journal of Gastroenterology|May 18, 2021
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
The American Journal of Gastroenterology|October 18, 2021
Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
Gut Microbes|December 22, 2016
Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approachMonika Fischer, Brian Sipe, Yao-Wen Cheng, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With CirrhosisParkpoom Phatharacharukul, Russell D Purpura, Devika Gandhi, et al.
Digestive Diseases and Sciences|January 12, 2019
Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?Jessica R Allegretti, Dina Kao, Emmalee Phelps, et al.
Gastro Hep Advances|March 19, 2026
<i>Clostridioides difficile</i> Infection: Harmonizing Patient CareJessica R Allegretti, Alpesh N Amin, Elizabeth L Hohmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2022
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionByron P Vaughn, Monika Fischer, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile InfectionMonika Fischer, Dina Kao, Zain Kassam, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Digestive Diseases and Sciences|October 8, 2017
Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-UpMonika Fischer, Sarah C Campbell, Cynthia S J Calley, et al.
Journal of Gastroenterology and Hepatology|March 8, 2021
Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infectionSanchit Gupta, Jinyi Zhu, Thomas R McCarty, et al.
The American Journal of Gastroenterology|May 18, 2021
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
The American Journal of Gastroenterology|October 18, 2021
Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
Gut Microbes|December 22, 2016
Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approachMonika Fischer, Brian Sipe, Yao-Wen Cheng, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With CirrhosisParkpoom Phatharacharukul, Russell D Purpura, Devika Gandhi, et al.
Digestive Diseases and Sciences|January 12, 2019
Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?Jessica R Allegretti, Dina Kao, Emmalee Phelps, et al.
Gastro Hep Advances|March 19, 2026
<i>Clostridioides difficile</i> Infection: Harmonizing Patient CareJessica R Allegretti, Alpesh N Amin, Elizabeth L Hohmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2022
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionByron P Vaughn, Monika Fischer, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile InfectionMonika Fischer, Dina Kao, Zain Kassam, et al.
Pageof 14